Advanced Search

Study Preview



Study Title and Description

Evaluation of a breast cancer risk prediction model expanded to include category of prior benign breast disease lesion.



Key Questions Addressed
1 Key Question 1. In adult women without preexisting breast cancer, what is the accuracy of risk assessment methods to identify women who could benefit from medications to reduce risk for primary breast cancer (e.g., clinical risk assessment models)? Key Question 1a. What is the optimal age at which to begin risk assessment to identify women who could benefit from medications to reduce risk for primary breast cancer? Key Question 1b. What is the optimal frequency of risk assessment to identify women who could benefit from medications to reduce risk for primary breast cancer?
  • Comments Comments (
    0
    ) |

Primary Publication Information
  • Comments Comments (
    0
    ) |
TitleData
Title Evaluation of a breast cancer risk prediction model expanded to include category of prior benign breast disease lesion.
Author Tamimi RM., Rosner B., Colditz GA.
Country Channing Laboratory, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts 02115, USA. rulla.tamimi@channing.harvard.edu
Year 2010
Numbers Pubmed ID: 20645399

Secondary Publication Information
There are currently no secondary publications defined for this study.


Extraction Form: Key Questions 1-4


Results & Comparisons

No Results found.